Industry / Jordan
Biologics: New Area For Investment
January 2010 | Industry Trend AnalysisAccording to the Jordanian Food and Drug Administration (JFDA), domestic drugmakers in the country are applying for permission to begin manufacturing biologics. As yet, no licences have been issued, meaning that all drug production in Jordan remains for pharmaceuticals only.
To read the full article, please sign in or take a free trial.



